The aim of this double-blind placebo-controlled study m to assess the effects of clinical state on tltdroencephalographic (EEG) sleep measures in elderly patients with recurrent major depression. We hypothesized that rapid-eye movement (REM) latency rnd delta sleep ratio would remain stable between actively dtpressed and remitted states (i.e., show state indqJerldence), and measures of sleep continuity would improve with remission (i.e., show state dependence). Fifteen elderly outpatients (mean age 65.3 years) had sIttp evaluations while ill and after remission, an average of 38 we eks later. All patients were in a double-blind p/Rcebo-maintenance condition at the time of follow-up studies. The major findings were: 1) no significant change in either REM latency or delta sleep ratio; 2) reduction in early morning awakening; and 3) improvement in subjective sleep quality despite the stability of most polysomnographic measures. We conclude that REM latency and delta sleep ratio are state independent in patients with late-life depression, and that early morning awakening and sleep quality improve with remission of symptoms. These findings suggest that EEG sleep changes may have significance for understanding the longitudinal course of depression in late life.
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fNeuropsychopharmacology 8: [143] [144] [145] [146] [147] [148] [149] [150] 1993] minutes), diminished delta sleep ratio (ratio of delta wave cpm in the frrst non-REM (NREM) period to delta wave cpm in the second NREM period: typically less than 1.1), and diminished overall sleep efficiency (typi cally 75% or lower), relative to healthy elderly control subjects (Reynolds et al. 1988) . Diminution in sleep efficiency often reflects the presence of increased wake fulness throughout the night, but particularly early morning awakening. Electroencephalographic (EEG) sleep changes are more pronounced in elderly de pressed, compared to middle-aged and young-adult pa tients (Gillin et al. 1981; Knowles and MacLean 1990; and Riemann and Berger 1989) . Such fIndings, partic ularly in the fIrst NREM-REM sleep cycle, have led to specifIc theoretical models of sleep regulation in major depression (see Reynolds et al. 1987) .
In mid-life depressed patients, persistent abnormal ities of sleep, such as reduced slow-wave sleep or re duced REM latency, have been documented following remission of depressive symptoms and discontinuation of antidepressant therapy (e.g., Hauri et al. [1974] found persistent reduction in slow-wave sleep, and Rush et aI. [1986] , Cartwright [1983] , and Thase and Simons [1992] reported persistent reduction in REM latency).
These fmdings suggest a trait-like characteristic that may persist regardless of the clinical status of depres sion and thus diff ers from the apparent state depen dence of other biologic correlates of depression. A long term follow-up study would be needed to show whether persistent shortening of REM latency is a true trait marker or represents physiologic lag ("scarring") in the recovery of sleep abnormalities in major depressive ill ness (Cartwright 1983) . We have recently presented data on EEG sleep changes during early continuation treatment with nor triptyline (NT) in elderly patients with recurrent major depression, showing that the best single correlates of clinical improvement during NT treatment were prolon gation of REM latency and increase of delta sleep ratio . Reduction in REM latency has been proposed as a correlate of relapse or recurrence in both mid-life (Giles et al. 1987 ) and late-life depres sion . Similarly, a reduction in delta sleep ratio to 1.1 or less has been found to be a correlate of early recurrence in mid-life depression (Kupfer et al. 1990 ). These are, therefore, the primary dependent variables of the present study.
This report is a sequel to our earlier study of sleep in early continuation therapy on NT; we now provide data on sleep during early maintenance treatment, af- 
SUBJECTS AND METHODS
The 15 outpatients described in Table 1 (Folstein et al. 1975 ) at the end of the H-day drug-free observation period. The end of the prior episode must have occurred within 2.5 years of !he start of the index episode, but with an interval of mnission of at least 3 months. An additional inclusion aiterion is that patients' medical illnesses be stable, non progressive, and considered to be under optimum med al management using medications not known to cause depression or changes in sleep. After a physical and neurologic examination and routine laboratory studies (complete blood count, electrolytes, liver, kidney, and thyroid functions tests, electrocardiogram, B 12 and fo late levels, chest x-ray, and urine analysis), patients' medical data were rated using the Cumulative Illness Rating Scale (Linn et al. 1968 ) to quantify concurrent medical burden. We have previously documented reli able ratings of chronic medical burden in elderly depressed patients (Miller et al. 1992) . Sleep data from a group of 15 age-and sex-equated healthy control subjects are provided for comparison. Data from these control subjects were also included as part of the 30 control subjects' data reported previously (Reynoldset al. 1991) . Depression ratings (HDRS, Beck Depression Inventory [BDI]), Global Assessment Scale (GAS) ratings, and sleep quality scores for the control subjects are provided in Table 1 .
Tltatment of Depression: Acute and Continuation Therapy
As previously reported (Reynolds et a1. 1991) , the in dex episode of depression was treated in open trial using a combination of NT and interpersonal psy chotherapy (Klerman et a1. 1984) , the latter modifIed for use in elderly patients (Frank et a1. in press) . To be entered into continuation (stabilization) therapy, pa tients were required to achieve and maintain for 3 con secutive weeks a HDRS score of 10 or lower, with steady-state plasma NT levels in the range of 50 to 150 ng/ml. Nortriptyline levels were determined using high-performance liquid chromatography (Foglia et al. 1987) . After 16 weeks of continuation treatment (HDRS scores at 10 or below), patients were randomly assigned 10 a maintenance therapy cell with either NT or placebo.
Patients assigned to a placebo condition were gradu aUy withdrawn from NT during a transition period of 6 weeks under double-blind discontinuation conditions. Sleep studies were then repeated 4 weeks into main tenance therapy (i.e., 4 weeks after discontinuation of NT and substitution of placebo tablets). The mean in terval between baseline sleep evaluation and sleep Sleep in Remitted Elderly Depressed Patients 145 evaluation early in maintenance was 38.4 weeks (SD: 5.9; range: 30.4 to 54.3 weeks). This interval consisted of the period of acute therapy (about 12 weeks on aver age), continuation therapy (16 weeks), transition to maintenance (6 weeks), and 4 weeks of maintenance therapy in a placebo condition.
As noted in Table 1 , patients had moderately se vere depressive symptoms (HDRS, BDI) and overall functional impairment ([GAS], Endicott et a1. 1976 ) at the time of baseline sleep assessment. Paired t-tests showed marked decrease in HDRS and BDI scores from baseline to early maintenance therapy and significant improvement in GAS ratings. Four of 15 patients had subsyndromal depressive symptoms (two with HDRS of 13; and two with scores of 14) at the time of T3 sleep assessment. The remaining 11 patients all had HDRS scores of less than 10.
Assessment of Sleep
Laboratory-based polysomnographic evaluation was performed at baseline (designated "Tl" for convenience) and during early maintenance therapy ("T3"). ("T2" evaluation during early continuation therapy with NT has been reported elsewhere, Reynolds et al. 1991 ). The scheduling of laboratory studies was determined by each subject's habitual sleep schedule at home, esti mated from data in a daily log completed over a 14-day period. On each occasion patients had 3 consecutive nights of polysornn ography in the Sleep and Chronobi ology Center of Western Psychiatric Institute and Clinic, including monitoring for sleep-disordered breathing, cardiac arrhythmia, and periodic limb movements on the first night of each series. Details of data acquisition and processing, including scoring reliability, have been described elsewhere (Reynolds et a1. 1988, and . High-and low-filter frequency settings (Grass model 780 polygraph) for the EEG and electrooculogram were 30 Hz and 0.3 Hz, respectively. Records were scored in 60-second epochs using the standard criteria specifIed by Kales and Rechtschaffen (1968) . In monthly checks of interrater reliability, we maintain agreement across 15 major sleep variables of 85% or better (range of vari ability across raters for REM latency is consistently un der 5%). In addition to visual scoring of records, auto mated (period) analyses of EEG slow-wave activity (0.5 to 3.0 Hz, 75 to 250 mY) were also conducted, using methods previously reported by Doman and Kupfer (1988) .
Subjective sleep quality was measured using the Pittsburgh Sleep Quality Index (PSQI) (Buysse et a1. 1989) , administered at the T1 and T3 sleep assessments. The PSQI score quantifIes various aspects of subjective sleep quality during the month preceding its adminis tration. Scores of five or lower reliably identify "good" sleepers.
Primary dependent variables were REM latency and delta sleep ratio. Rapid-eye movement latency is mea sured by the duration of the first NREM sleep period corrected for intervening wakefulness. We also present data on REM latency uncorrected for intervening wake fulness in Table I 
Statistical Analyses
Since the study used a within-subject repeated-mea sures design, we contrasted the T1 and T3 measures Baseline than did delta sleep ratio. Furthermore, although REM Iltency and delta sleep ratio were signifIcantly cor mated at T1 (r = 0.74, P = 0.002), they were not 5ignihcantly correlated at T3 (r = 0.18, NS), nor were !hey signifIcantly correlated in control subjects (r = 0.43, ... 15, P = 0.11). In depressed patients, variances were stable at both timepoints for delta sleep ratio (F = 2.06, , = 0.19) and REM latency (F = 1.53, P = 0.44), argu- • p < O.OS. t P < 0.01.
Maintenance
ing against a regression to the mean. However, it is notable that three sleep-onset REM periods present at T1 vanished at T3. Only one of eleven secondary sleep measures, early morning awakening, showed a statistically signi&cant change from illness (T1) to early remission on placebo (T3), decreasing from 35.9 (24.2) minutes to 22.4 (15.9) minutes (paired t = 2.18, n = 15, P < 0.05). The Pear- son analysis demonstrated signifIcant test-retest corre lations for five of eleven secondary variables: sleep latency, REM percent, phasic REM activity counts, REM density, and first REM period duration ( Table 2) . The scatterplots showed two outliers in the mea sures of T3 sleep (as determined by any value lying more than two standard deviations from the mean at that timepoint). One patient had an elevated T3 REM latency (110 minutes); a second patient had an elevated T3 delta sleep ratio (2.62). Although both patients had HDRS scores of 14 at the time of T3 sleep, neither has yet had a recurrence of major depression. Removing both pa tients from the analysis did not affect the results of the Tl to T3 comparisons. Thus, the reduction in early morning awakening from T1 to T3 was still signifIcant (paired t = 2.32, n = 13, P = 0.038), and all other sleep measures showed no change over time. Despite the sta bility of most sleep physiologic measures, improvement in subjective sleep quality was suggested by decreases in PSQI scores from 10.4 (3.8) at T1 to 6.9 (4.4) at T3 (paired t = 3.22, n = 15, P < 0.01).
SignifIcant patient-control group differences in HDRS, GAS, and PSQI scores persisted at T3, consis tent with our observation that four of fifteen patients were experiencing subsyndromal symptoms at the T3 sleep assessment. The change in PSQI for males was -3.4 (4.1) and for females, -3.6 (4.5). These means were not signifIcantly different. With the exception of sleep latency, no signifIcant control-patient differences in any EEG sleep measures were detected at Tl or T3.
DISCUSSION
To our knowledge, this is the first double-blind placebo controlled study of EEG sleep in recently remitted elderly depressed patients. The data demonstrate: 1) clinically signifIcant improvement, but not normaliza tion, in sleep quality scores (PSQI) accompanying im provement of depressive symptoms; 2) clinically and statistically signifIcant improvement in the polysomno graphic measure of early morning awakening; 3) no significant change in the primary dependent measures of REM latency and delta sleep ratio; 4) no change in 10 of 11 secondary measures of sleep continuity and sleep architecture, with SignifIcant test-retest correla tions in 6 of 13 variables from T1 to T3; and 5) a general absence of patient-control differences in EEG sleep measures at Tl and T3.
Thus, in response to our first question, most EEG sleep measures in late-life depression, with the excep tion of early morning awakening, appear not to change from illness to early remission on placebo, 4 weeks af ter discontinuation of NT. In response to our second question, both primary dependent variables, REM latency and delta sleep ratio, are state independent, but NEUROPSYCHOPHARMACOLOGY 1993-VOL. 8, NO.1 there may be more within-subject variability for delta sleep ratio than for REM latency. Finally, in response to our third question, early morning awakening is state dependent, and its decrease accompanies an improve· ment in subjective sleep quality. The general absence of patient-control differences in EEG sleep measures probably reflects limited statistical power. In our 1991 report, with numbers of 30 per cell, we were able to detect patient-control differences in sleep efficiency In our earlier report on EEG sleep in the same group of remitted depressed elders during early continuation therapy with NT (IT2"), we observed signifIcant in· creases in REM latency and delta sleep ratio relative to baseline (T1) values . The REM sleep percent was also signifIcantly decreased at T2 (during early continuation therapy with NT) relative to Tl, and sleep maintenance was signifIcantly in· creased. This pattern of change at T2 appears to reflect primarily drug effect, since, following gradual discon· tinuation of NT after random assignment to placebo and with continuing symptomatic remission, most sleep variables were similar at T3 (early maintenance, remit· ted, on placebo) and at T1 (baseline, ill, no tablet).
The clinical improvement in sleep quality at T3 ap· pears to be independent of all polysomnographic mea· sures with the possible exception of early morning awakening. This is a credible finding, consistent with Rodin et al. (1989) , who reported that complaints 01 sleep disturbance covaried longitudinally with severi�' of self-reported depressive symptoms in a random sample of community-residing elders. Respondents reported heightened sleep disturbance with early morn ing awakening during periods of heightened depres· sive symptoms. Similarly, in studies of healthy elders, we have also noted little correlation between sell· reported sleep quality and polysomnographic measures .
The current polysomnographic data are consistent with data from middle-aged depressed patients reo studied after remission of depressive symptoms and discontinuation of antidepressant medication (Rushet al. 1986 ). Although we cannot rule out the possibility of variance related to drug-discontinuation effects, we think that such effects are unlikely because medication was tapered slowly over 4 to 6 weeks and patients were completely off NT for 4 weeks before T3 sleep assess· ment. Moreover, the finding that REM latency does not increase predictably in recently remitted unmedicated elderly outpatients replicates two recent reports from with cognitive behavior therapy, and restudied in the slee p laboratory 1 month after remission of depressive symptoms, we found that the number of nocturnal lIOusals decreased in remitted patients (relative to par tialremitters and nonresponders) (Thase et al. submit led). T aken together, these fIndings suggest a disaggre gation of apparently trait-like or state-independent fea tures of depression (i. e., REM latency and delta sleep ratio) from more reactive and possibly state-dependent measures (Le., sleep continuity, including early morn ing awakening).
Our data are in partial agreement with those of Rie mann and Berger (1989) , who also noted an improve ment in parameters of sleep continuity between remit ted and depressed states. However, these authors detected a tendency for normalization of REM latency UldREM density in remission. Our data suggest a de aease in REM density from illness to remission that might become statistically signifIcant with a larger sam ple. Also, as noted, three sleep-onset REM periods dur ing ill ness were no longer present during remission.
The state independence of REM latency and delta slee p ratio suggests the utility of continuing follow-up studies to examine the relationship of sleep to further clinical course.
